Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Uncovering Genetic Factors in Leukemia
Disease Discoveries

Uncovering Genetic Factors in Leukemia

By Nora DunneJul 31, 2015
Share
Facebook Twitter Email
John Crispino
John Crispino, PhD, Robert I. Lurie, MD, and Lora S. Lurie Professor in Medicine-Hematology/Oncology and Biochemistry and Molecular Genetics, led a study that explains how the leukemia-promoting DYRK1A gene works in cells.

Northwestern Medicine scientists have discovered how a gene linked to leukemia functions, a finding that may have important implications for children with Down syndrome who have a higher risk of developing the blood cancer.

Patients with Down syndrome have three copies of chromosome 21 in their cells. They’re also 20 times more likely to contract childhood B-cell acute lymphoblastic leukemia than the general population, making that chromosome an important avenue for researching the genetic basis of the cancer.

“A major goal of my laboratory is to identify the specific gene – or genes – on chromosome 21 responsible for the increased incidence of leukemia in this population,” said study senior author John Crispino, PhD, Robert I. Lurie, MD, and Lora S. Lurie Professor in Medicine-Hematology/Oncology and Biochemistry and Molecular Genetics, and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

In previous work, Crispino and colleagues found that a gene on chromosome 21 called DYRK1A contributes to the development of leukemia. Now, in a paper published in the Journal of Experimental Medicine, they expanded on that research by studying the gene in depth. Specifically, they wanted to understand how DYRK1A plays a role in blood cell production. Over-production of immature lymphocytes is a hallmark of acute lymphoblastic leukemia.

With first author Benjamin Thompson, MD, PhD, a postdoctoral fellow, Crispino generated a mouse model that lacks DYRK1A in blood cells. They saw that two types of white blood cells called B and T lymphocytes were severely blocked from developing without the gene. The scientists also found evidence that DYRK1A is normally responsible for regulating cell cycle progression in those lymphocytes.

Because they have extra copies of chromosome 21, children with Down syndrome have more DYRK1A than usual.

“This finding is exciting to us because human B-cell acute lymphoblastic leukemia cases show increased levels of DYRK1A,” said Crispino. “The results suggest that DYRK1A may be a novel target for therapy in this form of leukemia.”

This work was supported by National Institutes of Health grant R01 CA101774, the Samuel Waxman Cancer Research Foundation, the Leukemia and Lymphoma Society, the Rally Foundation and the Bear Necessities Foundation.

Biochemistry Cancer Genetics Research
Share. Facebook Twitter Email

Related Posts

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Comments are closed.

Latest News

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Expanded Role for Calcium Channels in T-Cells

Jun 17, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077
20220607_Feinberg Campus_0063
20220607_Feinberg Campus_0111
20220607_Feinberg Campus_0083
20220607_Feinberg Campus_0018
20220607_Feinberg Campus_0023
20220607_Feinberg Campus_0072 (2)
20220607_Feinberg Campus_0120

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.